Why Achillion Pharmaceuticals Is Shooting 25% Higher Today

Why Achillion Pharmaceuticals Is Shooting 25% Higher Today

After the company updated investors on its second-quarter financials and the progress it's making in its clinical-stage drug pipeline, shares in Achillion Pharmaceuticals (NASDAQ: ACHN) are soaring 24% higher at 11:45 a.m. EDT today.

Since licensing its hepatitis C clinical-drug pipeline to Johnson & Johnson (NYSE: JNJ) in 2015, Achillion Pharmaceuticals has been knee-deep in developing new therapies for other indications. Yesterday afternoon, the company shared with investors its second-quarter performance and its clinical-stage pipeline progress. 

IMAGE SOURCE: GETTY IMAGES.

Continue reading

Source: Fool.com